Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. - Wikidata - wikimedia - TriplyDB

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

http://www.wikidata.org/entity/Q35907033

about

Epilepsy related to developmental tumors and malformations of cortical development Current view on the functional regulation of the neuronal K(+)-Cl(-) cotransporter KCC2 GABAergic signaling as therapeutic target for autism spectrum disorders Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.Pacemaker GABA synaptic activity may contribute to network synchronization in pediatric cortical dysplasia Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.Subunit composition of neurotransmitter receptors in the immature and in the epileptic brain.Genomic variants and variations in malformations of cortical development.Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures.Abnormal expression of cerebrospinal fluid cation chloride cotransporters in patients with Rett syndrome Cation-chloride cotransporters in neuronal development, plasticity and disease Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain Malformations of cortical development: clinical features and genetic causes Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex.Neonatal seizures alter NMDA glutamate receptor GluN2A and 3A subunit expression and function in hippocampal CA1 neurons.Regulatory domain or CpG site variation in SLC12A5, encoding the chloride transporter KCC2, in human autism and schizophrenia WONOEP appraisal: Development of epilepsy biomarkers-What we can learn from our patients?Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome.Basic mechanisms of epileptogenesis in pediatric cortical dysplasia.Therapeutic choices in convulsive status epilepticus.mTOR in Brain Physiology and Pathologies.Exploring novel AEDs from drugs used for treatment of non-epileptic disorders.Transcranial Magnetic and Direct Current Stimulation in Children.New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND).Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex.Enhanced expression of potassium-chloride cotransporter KCC2 in human temporal lobe epilepsy.Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy.A distinct microRNA expression profile is associated with α[11C]-methyl-L-tryptophan (AMT) PET uptake in epileptogenic cortical tubers resected from patients with tuberous sclerosis complex.Epilepsy in young Tsc1(+/-) mice exhibits age-dependent expression that mimics that of human tuberous sclerosis complex.Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex.

P2860

Q26829946-E9CAC009-E294-477A-93F3-C93624E2AEFF Q27004031-33FC565D-FBD6-4501-8647-22521BBCB015 Q27013583-CD548404-1259-4CD0-9DD2-5F30FA36086E Q30540852-3063FCD8-7FC9-4166-8B12-FA0216288152 Q30561131-B0FE8D07-1AA4-4158-A3FD-6721A305A7B6 Q33659830-99116598-2294-40D9-B54D-7EBC04172CDD Q34269737-D96AA911-88AD-4C3C-90D0-C5861E0495CC Q34478370-02ABB3FC-C8E5-415F-BA27-CDABFB0971FF Q34638960-BD8E8209-8D5E-4146-BEEB-2F682A1C7B24 Q34873355-6C910864-30E1-4276-B11F-F101E1ED9832 Q34959293-0AA0632B-C0A5-4133-83BE-5389CD12AD48 Q35003575-CA612E5C-6DBD-458B-828C-A15751E3C717 Q35188898-057957AF-1BB4-476B-BA97-1B47051F1909 Q36050518-AB16F7DD-7C29-44F2-9167-D447911BBBF4 Q36097671-DC92747C-36DC-4AD3-9161-B65939FE1EBA Q36145999-7C2B4D5F-F106-4223-B9BD-8595D07F01B2 Q36339575-1EB77D53-A72E-4E4C-98D9-D58C39675B3C Q36815367-8E94F8F0-8818-48A7-AAAF-C870E3D75528 Q37707250-4F52571B-156D-4FE7-BC3A-4479C52CE5E5 Q38268910-6C1D4701-F6CC-4A83-908E-482E88088E82 Q38334273-221B1F6A-F0D0-47FA-B814-9783F89728C0 Q38565769-3D514A70-410A-460F-A3EA-862D301A1CC0 Q38787286-8E02F55A-E0D1-479E-A10E-47DF57460ABF Q39147513-5CC6B383-78F0-4D81-965F-22680CFC999C Q39405847-9195E5D2-AAF0-4DFA-8D01-65313E39D5E6 Q41699644-D0BA4902-4DAE-4211-8EDE-F371014FC75F Q45971999-48069CC1-F420-401E-9AD1-CC102B95C454 Q47656486-877EAE86-E24B-4905-B99E-1ECB28AC5DA6 Q48027013-72F00554-82F3-4D7B-9FC9-8BD50DB1AEEC Q48909764-BB91D58C-5B47-41C5-A7C1-B8CC54B306B1 Q50343156-AF11BBC8-F3D1-4178-88C9-8D07BBD661FD

P2860

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

http://www.wikidata.org/entity/Q35907033

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

@ast

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

@en

type

label

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

@ast

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

@en

prefLabel

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

@ast

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

@en

P1433

Q35907033-CEA05A14-87DE-4662-B71D-224C3BF60745

P1476

Q35907033-688A8FC6-A0F8-45E6-8242-1A219C1C9263

P2093

Q35907033-05B09F0E-AE95-4A95-95B6-054DE534CBFC

Q35907033-0B2DAAA2-CCF8-4821-8A3F-A2EE098EE19E

Q35907033-1F62291F-004C-4F0F-B20A-1C284B04B176

Q35907033-2F4C99BB-067F-4B92-A79D-1FC30EE3A946

Q35907033-43151671-2ECA-42DD-A57C-7231C89EFA5B

Q35907033-451B3120-BDB8-451A-B5C5-BF8C1C6CF181

Q35907033-D3CFA62C-8DBE-465D-8A47-DA13D1B5B881

Q35907033-E4039C4A-E722-4B88-A3E6-FFF8224E4BCB

Q35907033-E98B3689-E86C-4A06-A46B-503060323ACA

P2860

Q35907033-01294301-6596-4311-B2D0-2905AB76015E

Q35907033-0E699A40-8F14-48CE-8340-FC94BAC95F64

Q35907033-16C7EF3F-B661-4466-8275-EA54C5DA6BA7

Q35907033-19E8EFD5-2AC8-4C4D-BDD5-75397CB49D29

Q35907033-1E4EB792-BE13-4776-A600-47BD060FEEFC

Q35907033-2207943E-E139-4A66-9FA8-B032D219CA6F

Q35907033-22F5BF4B-9468-475B-BC72-8A3E9B1581CA

Q35907033-25CD36B5-A9B9-43C4-95C4-17D325F3DF98

Q35907033-25D72773-7FE6-4EC8-AE9E-A6B89BFB61FF

Q35907033-289AE056-AE45-4CFC-8041-42F84904DE70

P304

Q35907033-6019673E-2CE7-4FF6-B076-267EAB8B00C4

P31

Q35907033-39B53894-F8D7-46FB-B890-DC5681FF96CC

P356

Q35907033-42581F6B-D0FD-4F8F-BDC2-B41D7CCC4B8B

P433

Q35907033-D763379A-E193-47CE-83E7-D8387D855D54

P478

Q35907033-E090A32D-B6AC-4E7B-B04F-ACF834BE20F7

P577

Q35907033-82904F48-B9C2-479C-8231-3FFFB346C9B7

P5875

Q35907033-0F962379-C185-44CC-984F-D95977C6D874

P698

Q35907033-A384CC50-7C08-4336-99DF-89DFC1912DB0

P932

Q35907033-FE52831C-6F80-4BEA-B9D1-F13936C2C31E

P356

P1433

Annals of Neurology

P1476

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

@en

P2093

Annapurna Poduri

http://www.w3.org/2001/XMLSchema#string

Annelise Joseph

http://www.w3.org/2001/XMLSchema#string

Bela Kosaras

http://www.w3.org/2001/XMLSchema#string

Delia M Talos

http://www.w3.org/2001/XMLSchema#string

Frances E Jensen

http://www.w3.org/2001/XMLSchema#string

Hongyu Sun

http://www.w3.org/2001/XMLSchema#string

Joseph R Madsen

http://www.w3.org/2001/XMLSchema#string

Peter M Black

http://www.w3.org/2001/XMLSchema#string

Rebecca D Folkerth

http://www.w3.org/2001/XMLSchema#string

P2860

The tuberous sclerosis complex

mTOR signaling: at the crossroads of plasticity, memory and disease

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

NKCC1 transporter facilitates seizures in the developing brain

Molecular characterization of a putative K-Cl cotransporter in rat brain. A neuronal-specific isoform

The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation

Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition

Excitatory actions of gaba during development: the nature of the nurture

Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits

Disrupted dentate granule cell chloride regulation enhances synaptic excitability during development of temporal lobe epilepsy.

P304

539-551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.22696

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221976393

http://www.w3.org/2001/XMLSchema#string

P698

22447678

http://www.w3.org/2001/XMLSchema#string

P932

3334406

http://www.w3.org/2001/XMLSchema#string